Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2025-12-26 @ 3:03 AM
Study NCT ID:
NCT00143520
Status:
COMPLETED
Last Update Posted:
2021-05-10
First Post:
2005-09-01
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Placebo and Active Controlled Study of Rivoglitazone in Type 2 Diabetes
Sponsor:
Daiichi Sankyo
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-12
Start Date Type:
None
Primary Completion Date:
2005-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-12
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-01
First Submit QC Date:
None
Study First Post Date:
2005-09-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-06
Last Update Post Date:
2021-05-10
Last Update Post Date Type:
ACTUAL